Arbutus Biopharma (ABUS) Interest Coverage Ratio Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) Interest Coverage Ratio Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - |
| 10 | Arbutus Biopharma | 872.93 Mn | 777.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 225.19% |
| Dec 31, 2025 | 14.16% |
| Sep 30, 2025 | -92.70% |
| Jun 30, 2025 | 45.16% |
| Mar 31, 2025 | -135.65% |
| Dec 31, 2024 | 41.09% |
| Sep 30, 2024 | -54.96% |
| Jun 30, 2024 | -121.83% |
| Mar 31, 2024 | 40.91% |
| Dec 31, 2023 | -44.52% |
| Mar 31, 2023 | 13.05% |
| Dec 31, 2022 | 15.28% |
| Sep 30, 2022 | 9.75% |
| Jun 30, 2022 | 36.63% |
| Mar 31, 2022 | 45.12% |
| Sep 30, 2021 | 20.40% |
| Jun 30, 2021 | 48.55% |
| Mar 31, 2021 | 14.94% |
| Dec 31, 2020 | -11.57% |
| Dec 31, 2019 | -519.65% |